SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,524,057,000 | -10.9% | 27,293 | -28.2% | 0.02% | -23.8% |
| Q1 2021 | $2,833,183,000 | -46.3% | 38,014 | +22.9% | 0.02% | -54.3% |
| Q4 2020 | $5,273,085,000 | +200.2% | 30,929 | +147.3% | 0.05% | +142.1% |
| Q3 2020 | $1,756,358,000 | -18.3% | 12,507 | -6.7% | 0.02% | -24.0% |
| Q2 2020 | $2,149,518,000 | +106.4% | 13,406 | +25.9% | 0.02% | +66.7% |
| Q1 2020 | $1,041,587,000 | -24.9% | 10,648 | -0.9% | 0.02% | +7.1% |
| Q4 2019 | $1,386,148,000 | – | 10,742 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |